Display options
Share it on

J Investig Med High Impact Case Rep. 2018 May 24;6:2324709618777003. doi: 10.1177/2324709618777003. eCollection 2018.

A Case of Concurrent Gastric and Pancreatic Plasmacytomas in a Patient With Multiple Myeloma: An Extremely Rare Entity.

Journal of investigative medicine high impact case reports

Tagore Sunkara, Santosh R Sharma, Andrew Ofosu, Vinaya Gaduputi, Madhavi Reddy, Ghulamullah Shahzad

Affiliations

  1. The Brooklyn Hospital Center, Clinical Affiliate of the Mount Sinai Hospital, Brooklyn, NY, USA.
  2. SBH Health System, Bronx, NY, USA.

PMID: 29854857 PMCID: PMC5971378 DOI: 10.1177/2324709618777003

Abstract

Multiple myeloma (MM), a plasma cell tumor, is primarily a disease of the bone marrow. Extramedullary plasmacytoma, also a plasma cell tumor, is very rare in the gastrointestinal tract and the pancreas, and only a handful cases have been documented till now. Gastric and pancreatic plasmacytomas are usually seen in elderly patients; however, cases in patients as young as 32 years of age have been reported. Commonly, patients with gastric plasmacytoma present with nonspecific symptoms like epigastric pain, abdominal fullness, anorexia, and weight loss, or serious conditions like massive upper gastrointestinal bleeding and gastric outlet obstruction. Patients with pancreatic plasmacytoma commonly present with obstructive jaundice. In this article, we present the case of a 79-year-old man with a history of MM for 3 years, diagnosed with gastric and pancreatic masses, which turned out to be plasmacytomas. To our knowledge, simultaneous occurrence of gastric and pancreatic plasmacytomas is extremely uncommon with less than 5 cases reported in the literature. We also compiled all the individual cases of gastric and pancreatic MM that have been reported in literature till now.

Keywords: extramedullary multiple myeloma; gastric plasmacytoma; multiple myeloma; pancreatic plasmacytoma

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

  1. Pathologe. 2015 Mar;36(2):193-6 - PubMed
  2. Skeletal Radiol. 1979;4(4):228-32 - PubMed
  3. Clin Lymphoma Myeloma. 2008 Dec;8(6):348-51 - PubMed
  4. Onkologie. 2009 Mar;32(3):119-21 - PubMed
  5. Cancer. 1991 Feb 1;67(3):681-3 - PubMed
  6. Gan No Rinsho. 1990 Nov;36(14):2491-5 - PubMed
  7. Endoscopy. 2015;47 Suppl 1 UCTN:E197 - PubMed
  8. Br J Haematol. 2004 Mar;124(6):717-26 - PubMed
  9. Histopathology. 1997 Oct;31(4):318-23 - PubMed
  10. Medicine (Baltimore). 2015 Jul;94(27):e914 - PubMed
  11. Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1013-7 - PubMed
  12. Gastroenterology. 2013 Sep;145(3):e1-2 - PubMed
  13. J Comput Assist Tomogr. 1985 Nov-Dec;9(6):1118-9 - PubMed
  14. J Med. 1991;22(3):195-9 - PubMed
  15. J Cancer Res Ther. 2010 Oct-Dec;6(4):549-51 - PubMed
  16. Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):789-94 - PubMed
  17. Case Rep Oncol Med. 2016;2016:6919210 - PubMed
  18. Ann Hematol. 2016 Mar;95(4):663-4 - PubMed
  19. Korean J Intern Med. 2015 Jul;30(4):538-9 - PubMed
  20. Eur J Gastroenterol Hepatol. 1999 Feb;11(2):205-7 - PubMed
  21. Am J Gastroenterol. 2014 Sep;109(9):1325 - PubMed
  22. Haematologica. 2006 Jul;91(7):964-7 - PubMed
  23. Clin Imaging. 2005 Jul-Aug;29(4):263-5 - PubMed
  24. AJR Am J Roentgenol. 2003 Feb;180(2):545-6 - PubMed
  25. Hum Pathol. 1982 Oct;13(10):940-2 - PubMed
  26. Arch Intern Med. 1978 Jul;138(7):1165-7 - PubMed
  27. Korean J Radiol. 2002 Apr-Jun;3(2):133-5 - PubMed
  28. Dig Dis Sci. 2007 Dec;52(12):3340-2 - PubMed
  29. J Med Case Rep. 2009 Aug 06;3:8785 - PubMed
  30. Expert Opin Biol Ther. 2017 Nov;17 (11):1375-1387 - PubMed
  31. Case Rep Radiol. 2012;2012:798264 - PubMed
  32. JAMA. 1978 Apr 28;239(17):1786-7 - PubMed

Publication Types